Non‐Selective Beta Blockers and PVT Risk: The Hemodynamic Perspective
Liver International · 2026-06 · 46 (6)
DOI: 10.1111/liv.70671 ↗Kurz gefasst
Leserbrief in der Zeitschrift Liver International, online erschienen am 03.05.2026. Verfasst von Yuanjian Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Zaozhuang Municipal Hospital, Jining Medical University, Zaozhuang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
Autor:innen und Institutionen
- Department of Hepatology, Zaozhuang Municipal Hospital, Jining Medical University, Zaozhuang, China.
ORCID-Profile: Yang Zhang
Zitieren
APA
Song, Y., Chen, Z., Zhou, B., & Zhang, Y. (2026). Non‐Selective Beta Blockers and PVT Risk: The Hemodynamic Perspective. Liver International, 46(6). https://doi.org/10.1111/liv.70671
Vancouver
Song Y, Chen Z, Zhou B, Zhang Y. Non‐Selective Beta Blockers and PVT Risk: The Hemodynamic Perspective. Liver International. 2026;46(6). doi:10.1111/liv.70671
BibTeX
@article{Song2026,
author = {Song, Yuanjian and Chen, Zhaobin and Zhou, Beibei and Zhang, Yang},
title = {Non‐Selective Beta Blockers and PVT Risk: The Hemodynamic Perspective},
journal = {Liver International},
year = {2026},
volume = {46},
number = {6},
doi = {10.1111/liv.70671}
}
EUVIMED